Nazario Carrabba Selected Research

Nazario Carrabba Research Topics

Disease

19	Myocardial Infarction 10/2017 - 08/2004
17	Thrombosis (Thrombus) 01/2023 - 04/2009
14	ST Elevation Myocardial Infarction 01/2023 - 05/2006
14	Coronary Artery Disease (Coronary Atherosclerosis) 01/2023 - 08/2006
10	Hemorrhage 01/2023 - 11/2010
8	Acute Coronary Syndrome 01/2020 - 01/2012
7	Cardiovascular Diseases (Cardiovascular Disease) 11/2023 - 03/2006
6	Cardiogenic Shock 02/2017 - 11/2006
5	Infarction (Infarctions) 01/2016 - 11/2010
5	Heart Failure 05/2013 - 04/2006
4	Stroke (Strokes) 01/2016 - 11/2010
4	Death (Near-Death Experience) 01/2016 - 12/2009
2	Cardiomyopathies (Cardiomyopathy) 11/2023 - 01/2022
2	Inflammation (Inflammations) 01/2023 - 07/2015
2	Chest Pain (Chest Pains) 01/2022 - 04/2011
2	Ventricular Remodeling 01/2016 - 03/2007
2	Left Ventricular Dysfunction 01/2014 - 12/2007
1	Cardiac Sudden Death (Sudden Cardiac Arrest) 11/2023
1	Disease Progression 01/2023
1	Cicatrix (Scar) 01/2023
1	Heart Diseases (Heart Disease) 01/2022
1	Aortic Valve Stenosis (Aortic Stenosis) 08/2021
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 01/2021
1	Fibrosis (Cirrhosis) 01/2021
1	Diabetes Mellitus 12/2015
1	Rupture 12/2015
1	Bundle-Branch Block (Fascicular Block) 07/2015
1	Chronic Kidney Failure (Chronic Renal Failure) 10/2014
1	Reperfusion Injury 01/2014
1	Non-ST Elevated Myocardial Infarction 12/2013
1	Acute Kidney Injury (Acute Renal Failure) 05/2013
1	Pulmonary Embolism 01/2012
1	Neoplasms (Cancer) 01/2012
1	Body Weight (Weight, Body) 01/2012
1	Ischemic Stroke 01/2012
1	Dyspnea (Shortness of Breath) 04/2011
1	Coronary Disease (Coronary Heart Disease) 12/2010
1	Hypertension (High Blood Pressure) 04/2006
1	Coronary Occlusion 03/2006
1	Unstable Angina 10/2005

Drug/Important Bio-Agent (IBA)

9	Prasugrel Hydrochloride FDA Link 01/2020 - 01/2012
7	Clopidogrel (Plavix)FDA Link 12/2015 - 12/2009
4	omega-Chloroacetophenone (Mace)IBA 01/2023 - 03/2006
4	Everolimus FDA Link 07/2017 - 10/2012
4	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 06/2014 - 01/2012
4	Creatine Kinase (Creatine Phosphokinase)IBA 05/2012 - 03/2007
3	Biomarkers (Surrogate Marker)IBA 01/2023 - 07/2015
3	TicagrelorIBA 01/2020 - 04/2013
3	Abciximab (ReoPro)FDA Link 01/2016 - 11/2010
2	GadoliniumIBA 01/2023 - 01/2021
2	cangrelorIBA 01/2023 - 07/2022
2	Pemetrexed (MTA)FDA Link 01/2016 - 06/2013
2	bivalirudin (Angiomax)FDA Link 06/2014 - 04/2013
2	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 06/2014 - 04/2013
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2013 - 12/2012
1	Glucose (Dextrose)FDA LinkGeneric 01/2023
1	InterleukinsIBA 01/2023
1	LipidsIBA 01/2023
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2023
1	C-Reactive ProteinIBA 01/2023
1	CalciumIBA 01/2018
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 10/2017
1	Thrombin FDA Link 11/2016
1	Doxycycline (Periostat)FDA LinkGeneric 01/2014
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 12/2013
1	Troponin IIBA 05/2013
1	Paclitaxel (Taxol)FDA LinkGeneric 10/2012
1	CarbonIBA 12/2010
1	Protamines (Protamine Sulfate)FDA Link 11/2010
1	Heparin (Liquaemin)FDA LinkGeneric 11/2010
1	Sirolimus (Rapamycin)FDA Link 10/2005

Therapy/Procedure

29	Percutaneous Coronary Intervention 01/2023 - 11/2004
21	Stents 01/2023 - 10/2005
16	Therapeutics 11/2023 - 08/2004
5	Drug-Eluting Stents 01/2012 - 03/2006
3	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 11/2023 - 01/2021
3	Thrombectomy 01/2016 - 06/2013
2	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2022 - 01/2022
2	Patient Readmission 04/2011 - 01/2007
1	Secondary Prevention 11/2023
1	Bioprosthesis 08/2021
1	Transcatheter Aortic Valve Replacement 07/2015
1	Catheters 06/2013
1	Anticoagulation Reversal 11/2010
1	Length of Stay 11/2010